Search

Search results

1. Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

   ... administering these drugs in patients with relapsed or refractory hematologic malignancies, including acute myeloid leukemia ... Enrollment: Participant has a relapsed or refractory hematologic malignancy (with any measurable disease) with ...

   Clinical Trial last updated 06/06/2016 - 10:04am.

2. Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug

   ... efficacious in a subset of patients with aplastic anemia refractory to IST, with frequent multilineage responses, and maintenance of ...

   Research Article last updated 01/07/2014 - 12:22pm.

3. HYPOMETHYLATING AGENTS (HMA) TREATMENT FOR MYELODYSPLASTIC SYNDROMES: ALTERNATIVES IN THE FRONTLINE AND RELAPSE SETTINGS

   ... an increasing focus on studying treatments for patients refractory to HMA treatment. Bone Marrow ...

   Research Article last updated 07/18/2017 - 1:15pm.

4. Types

   ... % blasts in bone marrow RA ( Refractory Anemia ) < 1 < 5 RARS (Refractory Anemia with Ring Sideroblasts < 1 ...

   Topic section last updated 11/14/2016 - 1:11pm.

5. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

   ... children, adolescents and young adults with relapsed or refractory hematologic malignancies Status:  ... ALL, and must have disease that has relapsed or is refractory to chemotherapy , or that has relapsed after HSCT. ...

   Clinical Trial last updated 05/09/2016 - 3:01pm.

6. Study of aplastic anemia med shows significant results

   ... efficacy. In patients with aplastic anemia that was refractory to immunosuppression, eltrombopag, a synthetic ...

   Article last updated 04/24/2017 - 7:14am.

7. The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS.

   ...

   Research Article last updated 07/29/2014 - 11:53am.

8. Phase I trial of SAR103168, a novel multi-kinase inhibitor,in patients with refractory/relapsed acute leukemias or high-risk myelodysplastic syndromes

   ...

   Research Article last updated 05/22/2014 - 9:43am.

9. Eltrombopag in refractory severe aplastic anemia

   ...

   Research Article last updated 04/16/2014 - 11:34am.

10. Alternative donor HSCT in refractory acquired aplastic anemia: The time has come

    ...

    Research Article last updated 07/31/2012 - 2:33pm.